Welcome to On the Record with Kevin and Tiffany, your go-to podcast for in-depth conversations on groundbreaking developments in science and technology. In this episode, join us as we dive deep into the transformative work of eGenesis, a trailblazing biotechnology company committed to reshaping the landscape of organ transplantation.

Get ready to explore how eGenesis, under the leadership of Dr. Mike Curtis, President and Chief Executive Officer, is on a mission to end the global transplant shortage, revolutionizing the treatment of organ failure along the way. Dr. Curtis is responsible for managing the development of eGenesis’ xenotransplantation programs, driving forward innovation in the field.

With their lead programs focusing on kidney and islet cell transplantation, eGenesis is at the forefront of innovation, bringing hope to countless individuals awaiting life-saving transplants.

Join Kevin and Tiffany as they uncover the fascinating journey of eGenesis, where science, compassion, and determination converge to create a brighter future for patients worldwide. Get ready for an insightful discussion that sheds light on the remarkable strides being made in the field of medical science.

Don't miss out on this compelling episode of On the Record, where Kevin and Tiffany bring you exclusive insights into the pioneering efforts of eGenesis and their quest to redefine the possibilities of organ transplantation. Tune in and be inspired by the stories of perseverance, innovation, and hope that are shaping the future of healthcare.

https://egenesisbio.com/